Ipca Laboratories informs about media release

06 Aug 2024 Evaluate

Ipca Laboratories has informed that it enclosed the media release issued by the Company with respect to launch of patented novel drug branded as ‘Diulcus’ in the Indian market for treatment of Diabetic Foot Ulcer (DFU). Currently there is a global unmet medical need for treatment of DFU which is the most prevalent complication caused by chronic diabetes.

The above information is a part of company’s filings submitted to BSE.


Ipca Laboratories Share Price

1485.80 8.55 (0.58%)
22-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1374.60
Zydus Lifesciences 883.85
Lupin 2165.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×